Mielóma multiplex: vizsgálatok itt: Kína
204 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleClinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- O&D BioTech Group CO., Limited
See details and how to joinNCT07369895 - No phaseTaking peopleNovel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07359014 - No phaseNot yet taking people in KínaApplication Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 30
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07353554 - 4. fázisNot yet taking people in KínaIsa-VRD in TIE HRMM
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 117
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07334535 - Korai 1. fázisTaking peopleJY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
- Where
- Foshan
- Életkor
- 18 év to 75 év
- People
- 9
- Run by
- Shenzhen Genocury Biotech Co., Ltd.
See details and how to joinNCT07336823 - No phaseNot yet taking people in KínaASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 159
- Run by
- Peking University People's Hospital
See details and how to joinNCT07320326 - 4. fázisTaking peopleIxazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05722405 - 2. fázisTaking peopleA Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 90
- Run by
- Shandong New Time Pharmaceutical Co., LTD
See details and how to joinNCT07312188 - No phaseTaking peopleLCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
- Where
- Beijing, Tianjin, Wuhan
- Életkor
- 18 év and over
- People
- 35
- Run by
- Nanjing Legend Biotech Co.
See details and how to joinNCT07100067 - No phaseTaking peopleRandomised Controlled Trial of Artificial Intelligence-assisted Health Education
- Where
- Wuhan
- Életkor
- 18 év to 90 év
- People
- 196
- Run by
- Zhongnan Hospital
See details and how to joinNCT07305337 - No phaseTaking peopleReal-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07296627 - Korai 1. fázisTaking peopleA Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
- Where
- Nanjing, Shanghai, Xi'an, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 36
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07294625 - 1. fázisTaking peopleA Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
- Where
- Chengde, Chongqing, Guangzhou, Heze, Nanchang, Nanchong, Nanjing, Shanghai, Suzhou, Tangshan, Tianjin, Xi’an
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07179679 - No phaseTaking peopleUniversal CAR-T Cell Therapy for MM
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 6
- Run by
- Bioray Laboratories
See details and how to joinNCT07248176 - 1. fázisTaking peopleDual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07003555 - 1. fázisTaking peopleDual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07003568 - 1. fázisTaking peopleAllogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Xi'an No.3 Hospital
See details and how to joinNCT07139509 - Korai 1. fázisTaking peopleCAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 9
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07249073 - No phaseTaking peopleHigh-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Where
- Xining
- People
- 1000
- Run by
- Yigeng Cao,MD,PhD
See details and how to joinNCT07205523 - Korai 1. fázisTaking peopleA Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 24
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06730256 - 3. fázisNot yet taking people in KínaStudy of CM336 in Relapsed or Refractory Multiple Myeloma Patients
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 280
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT07181239 - 1. fázisTaking peopleBCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
- Where
- Chengdu, Shenzhen
- People
- 12
- Run by
- iCell Gene Therapeutics
See details and how to joinNCT04162353 - No phaseNot yet taking people in KínaRisk-adapted Therapeutic Strategy in +1q NDMM
- Where
- Changchun
- People
- 200
- Run by
- FengYan Jin
See details and how to joinNCT07045168 - No phaseTaking peopleA Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
- Where
- Changzhou, Nanjing, Nantong, Taizhou, Yancheng
- Életkor
- 65 év and over
- People
- 112
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06497738 - 1/2. fázisTaking peopleSafety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
- Where
- Beijing, Guangzhou, Hangzhou
- Életkor
- 18 év and over
- People
- 84
- Run by
- Zhejiang ACEA Pharmaceutical Co. Ltd.
See details and how to joinNCT05565807